Multiplan

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders took advantage of biotech initial public offerings. Some insiders were making return trips to the buy window to increase their stakes. Conventional wisdom says that...

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders added to their stakes in REITs, a specialty retailer and a packaged foods giant. Some insiders were making return trips to the buy window to increase their stakes....

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders were adding to their stakes in the wake of earnings reports. A few biopharmaceutical companies saw insiders acquiring some shares as well. Conventional wisdom says that...

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insiders at some consumer products companies were adding to their stakes this past week. A few biotech companies saw insiders acquiring some shares as well. Conventional wisdom says that insiders...

An ETF based on special purpose acquisition companies that trades on a U.S. exchange is now available to investors for the first time.  About The New ETF: The Defiance NextGen SPAC IPO ETF (NYSE: SPAK) began trading Thursday. The ETF will hold common stock of newly issued SPACs (ex-...

Entrepreneur and "Shark Tank" judge Kevin O’Leary shared his takeaways on special purpose acquisition companies Tuesday on CNBC’s "Halftime Report."  Investing in Leadership: O’Leary said it’s smart to invest in operators with a "long track...

Michael Klein, one of the prominent names in the special purpose acquisition sector, is back with his fifth offering. The SPAC's Management Team: Churchill Capital Corp V (NYSE: CCV.U) will be led by Klein, who is also the founder and managing partner of M. Klein and Co. Klein spent over 20...

Multiplan on Sunday announced the company had reached a merger deal with special purpose acquisition company (SPAC) Churchill Capital III Corp. (NYSE: CCXX), which values the company at $11 billion. What Happened The merger will allow the healthcare solutions provider to go public without...